Refine Results
RNA sequencing identifies differences in immune profiles of tumors from...

RNA sequencing for insights into immuno-oncology research

Classification of the human gut microbiome using a validated 16S rRNA next...

Analysis of the gut microbiome composition

Validated next generation sequencing (NGS) assay for the characterization...

GCP validated NGS assay

Validated next generation sequencing (NGS) RNA-based assay of the IGHV...

NGS-based IGHV assay

Robust TMB values derived from tumor-only material

Tumor mutational burden (TMB) for prediction of immunotherapy response

A Pan-Cancer View of the Immune Landscape in the Tumor Microenvironment...

Immune-based biomarkers for measurement of tumor microenviornment (TME)

Tumor Mutational Burden (TMB) analysis across multiple genomic platforms...

Why Tumor Mutational Burden (TMB)?

A Pan-cancer View of Immune Cell Activity, Immune Checkpoints and Tumor...

Aspects of immune cell activity and their pro and anti-tumor characteristics

Vaccine and Infectious Disease Testing Capabilities

End-to-end Laboratory Testing for Infectious Diseases and Vaccine Development

Immune Landscape Signatures from Gene Expression Analysis of Human Tumors

Signatures characterizing key immune cell subtypes, pathways, and individual genes

Significant Developments, Trends and Approaches in Next Generation Flow...

Q&A with Mark Edinger

A Next Generation Sequencing (NGS) Approach to Influenza Vaccine...

NGS influenza typing assay for vaccine and therapeutic development